T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Globant
GLOB
$1.68B
| $500M | 0.08% |
2,670,352
+1,602,875
| +150% | +$331M |
|
|
KRTX
227
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $498M | 0.08% |
2,216,146
+191,307
| +9% | +$38.7M |
|
228
Rayonier
RYN
$6.52B
| $496M | 0.08% |
18,259,990
-1,492,500
| -8% | -$48.2M |
|
229
Broadridge
BR
$19.1B
| $486M | 0.08% |
3,365,719
-935,384
| -22% | -$152M |
|
230
Public Storage
PSA
$61B
| $486M | 0.08% |
1,658,834
+2,053
| +0.1% | +$668K |
|
|
XYZ
231
Block Inc
XYZ
$48.4B
| $485M | 0.08% |
8,777,147
-3,924,878
| -31% | -$278M |
|
232
Marriott International
MAR
$92.7B
| $485M | 0.08% |
3,462,276
-888,088
| -20% | -$136M |
|
233
Live Nation Entertainment
LYV
$43.3B
| $478M | 0.08% |
6,282,683
-979,158
| -13% | -$87.7M |
|
234
Sanofi
SNY
$105B
| $472M | 0.08% |
12,296,876
-4,947,478
| -29% | -$220M |
|
235
WEC Energy
WEC
$35.7B
| $468M | 0.08% |
5,228,457
-674,459
| -11% | -$68.9M |
|
|
HOLX
236
DELISTED
Hologic
HOLX
| $468M | 0.08% |
7,253,528
-27,431,310
| -79% | -$1.9B |
|
237
Textron
TXT
$15B
| $461M | 0.08% |
7,912,210
-25,636,560
| -76% | -$1.63B |
|
238
Sysco
SYY
$40.5B
| $460M | 0.08% |
6,508,791
+323,794
| +5% | +$27M |
|
239
PayPal
PYPL
$50.9B
| $450M | 0.07% |
5,175,591
-798,630
| -13% | -$70.8M |
|
240
TechnipFMC
FTI
$29.7B
| $449M | 0.07% |
53,044,449
-11,718,508
| -18% | -$92.3M |
|
241
Exelon
EXC
$46.8B
| $447M | 0.07% |
11,930,788
+9,899,186
| +487% | +$438M |
|
242
International Flavors & Fragrances
IFF
$21.5B
| $443M | 0.07% |
4,881,963
-7,206,573
| -60% | -$826M |
|
243
Best Buy
BBY
$17.9B
| $440M | 0.07% |
6,945,507
+2,099,663
| +43% | +$156M |
|
244
CME Group
CME
$94.8B
| $435M | 0.07% |
2,456,182
-1,934,128
| -44% | -$382M |
|
245
Bristol-Myers Squibb
BMY
$132B
| $433M | 0.07% |
6,085,494
-8,501,529
| -58% | -$617M |
|
246
Huazhu Hotels Group
HTHT
$12.5B
| $431M | 0.07% |
12,863,406
-978,258
| -7% | -$37M |
|
|
SEM
247
DELISTED
Select Medical
SEM
| $430M | 0.07% |
36,093,239
-6,616,710
| -15% | -$94M |
|
248
Welltower
WELL
$169B
| $429M | 0.07% |
6,675,723
-2,556,160
| -28% | -$200M |
|
249
Ball Corp
BALL
$16.5B
| $419M | 0.07% |
8,665,007
-18,630,130
| -68% | -$1.15B |
|
250
Kanzhun
BZ
$6.89B
| $415M | 0.07% |
24,604,622
+4,113,569
| +20% | +$92.8M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.